Chart: ACC 2010: Clinical Trial Data To Look For
This article was originally published in The Gray Sheet
You may also be interested in...
SORT-OUT III Trial Shows More Stent Thrombosis With Endeavor Than Cypher
New data from Scandinavia suggests Medtronic's Endeavor zotarolimus-eluting stent may be less safe than competing drug-eluting stents
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.